Home NDC 83853-101 AQNEURSA
Product NDC 83853-101
11-digit product format 838530101
Labeler code 83853
Product ID 83853-101_ee142544-e5d9-41b1-8bbd-50f47d1ce6e9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name levacetylleucine
Dosage form GRANULE, FOR SUSPENSION
Route ORAL
Labeler IntraBio Inc
Application NDA219132
Marketing category NDA
Marketing start 2024-09-24
Substance LEVACETYLLEUCINE
Active strength 1000 mg/1
Pharmacologic classes Bile Salt Export Pump Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219132-001 AQNEURSA LEVACETYLLEUCINE 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219132-001 11400067 2037-04-19 U-4170 2025-04-22 N219132-001 12144792 2037-04-19 U-4603 2026-09-23 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 N219132-001 12433863 2037-04-19 U-4285 2025-10-22
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219132-001 I-1000 2029-09-18 N219132-001 NCE 2029-09-24 N219132-001 ODE-498 2031-09-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 2680178bc6a6…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 d06236e962d9…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219132-001 AQNEURSA 1GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2024-09-24 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219132-001 12144792 2037-04-19 U-4603 2026-09-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219132-001 12144792 2037-04-19 U-4603 2026-09-23 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219132-001 11400067 2037-08-11 U-4170 2025-04-22 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219132-001 11400067 2037-04-19 U-4170 2025-04-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219132-001 12433862 2037-04-19 U-4284 2025-10-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219132-001 12433863 2037-04-19 U-4285 2025-10-22 a50c72e98297…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base AQNEURSA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LEVACETYLLEUCINE 1000 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination E915HL7K2O Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2693617 Internal RxNorm lookup 2693623 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 83853-101-01 AQNEURSA 1 in 1 PACKET GRANULE, FOR SUSPENSION 1 5 83853-101-01 AQNEURSA 28 in 1 CARTON GRANULE, FOR SUSPENSION 28 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 83853-101 AQNEURSA (LEVACETYLLEUCINE) GRANULE, FOR SUSPENSION [INTRABIO INC] 5 Current NDC, 2 package rows 20250125_0f248e55-d1bb-13f9-e063-6294a90a05ce.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 83853-101-01 83853010101 28 PACKET in 1 CARTON (83853-101-01) / 1 GRANULE, FOR SUSPENSION in 1 PACKET 28 packet 2024-09-24 No No Current